Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease

This secondary analysis of the Examining Use of Ticagrelor in Peripheral Artery Disease (EUCLID) trial examines the risk of ischemic events in patients with peripheral artery disease (PAD) and polyvascular disease (PAD with coronary artery disease [CAD] and/or cerebrovascular disease [CVD]).

Read the full article here

Related Articles